New era for anticoagulant therapy
Links shared publicly online about this topic.
- 635total visits
New era for anticoagulant therapy
View full resource at news-medical.net
Tags: Stroke, Thrombotic Event, FDA, Anti-Clotting Medication, Anticoagulant, Boehringer Ingelheim, News
Most Recently Shared on December 23, 2010 at 12:45 am By:
Stroke News: New era for anticoagulant therapy: In a Guest Editorial published in the new publication Clinical... http://twurl.nl/iei23e
American College of Surgeons Surgery News UPDATE: New Anticoagulants Promising but Problematic
facs.org — “Because anticoagulation is a balancing act between the prevention of clots and the risk of major bleeds, tremendous efforts have been made to find the safest, most effective drugs possible. The foundations of anticoagulant therapy – warfarin (taken orally) and heparin (taken intravenously) – are being shaken by an onslaught of the newer oral factor Xa inhibitors.” View full resource at facs.org
Most Recently Shared on March 10, 2012 at 5:26 pm By:
Chris Porter Doctor, Surgeon, and Physician
New Anticoagulants Promising but Problematic http://t.co/CyCzDzBA
CardioSource - Top Content
cardiosource.org — “CardioSource - Top Content” View full resource at cardiosource.org
Most Recently Shared on March 9, 2012 at 5:05 pm By:
AmerColl Cardiology Cardiology and Medical Society
Top 10 Journal Scans & Clinical Trial Summaries from February: http://t.co/PM1AG17R
HCV New Drug Research: PSI-7977 plus ribavirin -A 'Newer' Era of HCV Therapy Begins?
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: PSI-7977 plus ribavirin -A 'Newer' Era of HCV Therapy Begins?” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on December 16, 2011 at 8:53 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
PSI-7977 plus ribavirin -A 'Newer' Era of HCV Therapy Begins? http://t.co/DRog5jAe
HCV New Drug Research: PSI-7977 plus ribavirin -A 'Newer' Era of HCV Therapy Begins?
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: PSI-7977 plus ribavirin -A 'Newer' Era of HCV Therapy Begins?” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on December 16, 2011 at 8:37 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
PSI-7977 plus ribavirin -A 'Newer' Era of #hepatitis C Therapy Begins? http://t.co/kY0pw3hG
Stem Cell Therapy: A Process With a Promise | Xconomy
xconomy.com — “Stem cells hold the promise of ushering in a new era of regenerative medicine, as scientists and engineers have made significant progress in directing these” View full resource at xconomy.com
Most Recently Shared on October 11, 2011 at 2:24 am By:
Scott Strumello Patient Expert
Stem Cell Therapy: A Process With a Promise http://t.co/4TcGvbym
Apixaban Rides Wave of Praise, but Future No Slam-Dunk - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- PARIS — It’s be a long time since there were royals living here in the city of lights, but an investigational drug — apixaban (Eliquis) -- received regal treatment here, with one researcher proclaiming the end of the warfarin era for anticoagulation in non-valvular atrial fibrillation and the dawn of a new age.” View full resource at qualitypointtech.net
Most Recently Shared on September 4, 2011 at 2:45 pm By:
Apixaban Rides Wave of Praise, but Future No Slam-Dunk: (MedPage Today) -- PARIS — It’s be a long time since t... http://t.co/sRrpyVl
One in three AF patients at high risk of stroke are not being prescribed VKA therapy
news-medical.net — “New data show that, worldwide, one in three patients with atrial fibrillation (AF) who are at high risk for stroke are not being prescribed anticoagulant therapy, particularly vitamin K antagonists (VKA) – medicines known to significantly lower stroke risk in these patients.” View full resource at news-medical.net
Most Recently Shared on August 29, 2011 at 9:30 am By:
One in three AF patients at high risk of stroke are not being prescribed VKA therapy: New data show that, worldw... http://t.co/ftCw7yh
Stem cell breakthrough heralds new era of therapy development
medicalxpress.com — “Scientists at the Universities of Glasgow and Southampton have uncovered a new method for culturing adult stem cells which could lead to the creation of revolutionary stem cell therapies for conditions such as arthritis, Alzheimer's disease and Parkinson's disease.” View full resource at medicalxpress.com
Most Recently Shared on July 18, 2011 at 1:39 pm By:
PhysOrg Health News Health News
Stem cell breakthrough heralds new era of therapy development http://tw.medicalxpress.com/230200611
July 1, 2011: Computer Assisted Therapies in a Brave New World | VEOMED
veomed.com — “July 1, 2011: Computer Assisted Therapies in a Brave New World | VEOMED” View full resource at veomed.com
Most Recently Shared on July 13, 2011 at 4:45 pm By:
Computer Assisted Therapies in a Brave New World. K Carroll, MD Prof of Psychiatry Yale University School of Medicine http://ow.ly/5BC59
Fight against sepsis: Fibrin, a product of the blood clotting process, is key to protection during gram-negative sepsis
sciencedaily.com — “New research may help to explain why anticoagulant therapies have largely failed to extend the lives of patients with sepsis. The study shows that fibrin, a key product of the blood clotting process, is critical for host defense against Yersinia enterocolitica, a gram-negative bacterium that causes sepsis in humans and experimental mice.” View full resource at sciencedaily.com
Most Recently Shared on July 13, 2011 at 4:57 am By:
Matthew Bowdish MD Physician, Doctor, Internist, and Allergist
Fight Against Sepsis: Fibrin, a Product of the Blood Clotting Process, Is Key to Protection During Gram-Negative Sepsis http://bit.ly/nyGCU1
Fight against sepsis: Fibrin, a product of the blood clotting process, is key to protection during gram-negative sepsis
sciencedaily.com — “New research may help to explain why anticoagulant therapies have largely failed to extend the lives of patients with sepsis. The study shows that fibrin, a key product of the blood clotting process, is critical for host defense against Yersinia enterocolitica, a gram-negative bacterium that causes sepsis in humans and experimental mice.” View full resource at sciencedaily.com
Most Recently Shared on July 11, 2011 at 5:06 pm By:
Fight against sepsis: Fibrin, a product of the blood clotting process, is key to protection during gram-negative sepsis http://bit.ly/ptdUIx
Researchers announce discovery in fight against sepsis
medicalxpress.com — “New research from the Trudeau Institute may help to explain why anticoagulant therapies have largely failed to extend the lives of patients with sepsis. The study was led by Deyan Luo, a postdoctoral fellow in Stephen Smiley's laboratory. It shows that fibrin, a key product of the blood clotting process, ...” View full resource at medicalxpress.com
Most Recently Shared on July 11, 2011 at 4:36 pm By:
PhysOrg Health News Health News
Researchers announce discovery in fight against sepsis http://tw.medicalxpress.com/229606573
Two Studies Herald New Era in Melanoma Therapy
onclive.com — “New treatment approaches that improve overall survival for patients with late-stage melanoma spotlighted” View full resource at onclive.com
Most Recently Shared on June 6, 2011 at 3:08 pm By:
Two Studies Herald New Era in Melanoma Therapy http://goo.gl/Rit5f #ASCO11
Drugs Will Not Replace RCC Surgery - Renal and Urology News
renalandurologynews.com — “ORLANDO--"New targeted therapies for locally advanced and metastatic renal cell carcinoma (RCC) have ushered in a new era in systemic therapy, according to Christopher Wood, MD, Professor of Urology at the University of Texas M.D. Anderson Cancer Center in Houston.” View full resource at renalandurologynews.com
Most Recently Shared on April 18, 2011 at 2:22 pm By:
Renal Urology News Nephrology, Urology, Medical Publisher, and Health News
Drugs Will Not Replace RCC Surgery: ORLANDO—New targeted therapies for locally advanced and metastatic renal cel... http://bit.ly/fO30U6
HCV New Drug Research: Boceprevir, Telaprevir to Usher in New Era of Hepatitis C Therapy
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Boceprevir, Telaprevir to Usher in New Era of Hepatitis C Therapy” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 16, 2011 at 3:10 am By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Boceprevir, Telaprevir to Usher in New Era of Hepatitis C Therapy http://goo.gl/fb/nBCwY
Advertisement
